30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
AUTOR(ES)
Bonadonna, Gianni
FONTE
BMJ Publishing Group Ltd.
RESUMO
Objective To assess the long term effectiveness of adjuvant treatment with cyclophosphamide, methotrexate, and fluorouracil (CMF) in patients with operable breast cancer at risk of relapse, on the basis of three successive randomised trials and one observational study conducted from June 1973 to December 1980.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=546063Documentos Relacionados
- Fetal growth and subsequent risk of breast cancer: results from long term follow up of Swedish cohort
- Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial
- Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial
- CMF adjuvant chemotherapy for breast cancer achieves good long term results
- Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831
